Vibrotactile Therapy for Stroke
Trial Summary
What is the purpose of this trial?
The purpose of our study is to evaluate Vibrotactile Coordinated Reset stimulation (vCR) and its effects on motor ability within stroke patients. vCR will be administered with a device called the Vibrotactile (VT) Brain Glove. vCR is expected to provide patients with a non-invasive therapy to aid in recovery from a stroke. This study will include a dedicated sham arm that will aid in understanding true treatment effects from vCR.
Will I have to stop taking my current medications?
The trial requires that participants do not take medications that affect balance. If you are on such medications, you may need to stop them to participate.
What data supports the effectiveness of the treatment Vibrotactile Coordinated Reset for stroke patients?
Research suggests that vibrotactile feedback, which involves using vibrations to provide sensory information, can be a safe and helpful approach for improving balance and hand function in patients with neurological conditions, including stroke. Studies have shown that using sensory noise, like vibrations, can improve hand dexterity and strength in stroke survivors, indicating potential benefits for similar vibrotactile therapies.12345
Is vibrotactile therapy safe for humans?
Vibrotactile therapy has been studied for safety in stroke survivors, with one study finding it generally safe for daily use over a month, although some mild adverse effects like worsened sensory scores were reported. Another review suggests it could be a safe approach for balance and gait rehabilitation in neurological conditions, but more high-quality studies are needed to confirm this.12678
How is Vibrotactile Coordinated Reset treatment different from other stroke treatments?
Vibrotactile Coordinated Reset is unique because it uses vibrations to stimulate the sense of touch, which can help improve motor function and balance in stroke patients by enhancing sensory feedback and motor activation. This approach is different from traditional therapies as it integrates multisensory information and provides augmented feedback to promote recovery.123910
Research Team
Peter Tass, MD, Ph.D
Principal Investigator
Stanford University
Eligibility Criteria
This trial is for adults aged 18-80 who've had a stroke at least 6 months ago, have some motor function left, and can mentally engage (score of ≥24 on a mental state exam). They shouldn't be on balance-affecting meds or have other major neurological issues, severe joint stiffness, recent spasticity treatments except bracing/splinting, or be pregnant/breastfeeding.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Vibrotactile Coordinated Reset stimulation using the Vibrotactile Brain Glove
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Vibrotactile Coordinated Reset
Find a Clinic Near You
Who Is Running the Clinical Trial?
Stanford University
Lead Sponsor